The early synthesis of p35 and activation of CDK5 in LPS-stimulated macrophages suppresses interleukin-10 production.
Yi Rang Na, Daun Jung, Gyo Jeong Gu, Ah Ram Jang, Yoo-Hun Suh, Seung Hyeok Seok
Index: Sci. Signal. 8 , ra121, (2015)
Full Text: HTML
Abstract
Interleukin-10 (IL-10) is an important anti-inflammatory cytokine that is produced primarily by macrophages. We investigated mechanisms by which the timing of IL-10 production was controlled in macrophages and found that cyclin-dependent kinase 5 (CDK5) activity was markedly increased in lipopolysaccharide (LPS)-stimulated macrophages through the synthesis of the CDK5-binding partner and activator p35. Degradation of p35 released the inhibition on anti-inflammatory signaling mediated by CDK5-p35 complexes. The transiently active CDK5-p35 complexes limited the LPS-stimulated phosphorylation and activation of various mitogen-activated protein kinases (MAPKs), thereby preventing the premature production of SOCS3 (suppressor of cytokine signaling 3), an inhibitor of inflammatory responses in macrophages, and IL-10. Furthermore, we showed that dextran sodium sulfate failed to induce colitis in p35-deficient mice, which was associated with the enhanced production of IL-10 by macrophages. Together, our results suggest that CDK5 enhances the inflammatory function of macrophages by inhibiting the MAPK-dependent production of IL-10.Copyright © 2015, American Association for the Advancement of Science.
Related Compounds
Related Articles:
2014-01-01
[MBio 5(5) , e01921-14, (2014)]
2015-03-01
[J. Virol. 89(5) , 2698-709, (2015)]
2014-07-01
[Infect. Immun. 82(7) , 3033-44, (2014)]
2014-11-01
[J. Immunol. 193(9) , 4527-36, (2014)]
2015-03-14
[Br. J. Nutr. 113(5) , 770-82, (2015)]